Serotonin Transporter Polymorphism Mediates Vulnerability to Loss of Incentive Motivation Following Acute Tryptophan Depletion

The serotonin (5-HT) system is implicated in incentive motivational processes. The present study utilized the acute tryptophan depletion (ATD) procedure to investigate the effect of temporarily lowering 5-HT synthesis on motivation in healthy volunteers, stratifying the results by allelic variation at the serotonin transporter gene (5-HTTLPR). ATD resulted in a robust reduction in plasma tryptophan concentration. Consistent with a previous study, ATD attenuated motivationally speeded action on the Cued-Reinforcement Reaction Time task. The present investigation revealed that this effect was restricted to volunteers of the ss genotype, whereas ll volunteers exhibited intact motivationally speeded action following ATD (treatment × reinforcement probability × genotype interaction: F1,26=5.8, p=0.024). Furthermore, tryptophan availability to the brain was correlated positively with motivationally speeded action following ATD in the ss genotype group (ρ13=0.71, p=0.006), whereas this correlation was negative in the ll genotype group (ρ14=−0.60, p=0.023). This is the first study to suggest that allelic variation at the 5-HTTLPR mediates motivational responses to ATD in healthy volunteers. These data indicate that the s allele at the 5-HTTLPR may confer risk for depression via its effect on incentive motivational processing, and highlight the importance of genetic variation in determining individual responses to pharmacological treatments.

[1]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[2]  R. Wurtman,et al.  Brain serotonin content: physiological regulation by plasma neutral amino acids. , 1997, Science.

[3]  D. C. Howell.  Statistical Methods for Psychology , 1987 .

[4]  P. Stehle,et al.  Appraisal of four pre-column derivatization methods for the high-performance liquid chromatographic determination of free amino acids in biological materials. , 1990, Journal of chromatography.

[5]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[6]  C. J. Schmidt,et al.  5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. , 1992, European journal of pharmacology.

[7]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[8]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[9]  Y. Minabe,et al.  The depletion of brain serotonin levels by para‐chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: An extracellular single cell recording study , 1996, Synapse.

[10]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[11]  JaneR . Taylor,et al.  Supranormal Stimulation of D1 Dopamine Receptors in the Rodent Prefrontal Cortex Impairs Spatial Working Memory Performance , 1997, The Journal of Neuroscience.

[12]  KA Smith,et al.  Relapse of depression after rapid depletion of tryptophan , 1997, The Lancet.

[13]  O. Magnusson,et al.  Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study , 1997, Neuroscience Letters.

[14]  D. Easton,et al.  Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. , 1998, American journal of medical genetics.

[15]  E. Smeraldi,et al.  Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine , 1998, Molecular Psychiatry.

[16]  P. De Deurwaerdère,et al.  Opposite Change of In Vivo Dopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors , 1998, The Journal of Neuroscience.

[17]  K. Berridge,et al.  What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.

[18]  R. Elliott,et al.  Ventromedial prefrontal cortex mediates guessing , 1999, Neuropsychologia.

[19]  Jonathan D. Cohen,et al.  Role of locus coeruleus in attention and behavioral flexibility , 1999, Biological Psychiatry.

[20]  M. Molliver,et al.  Dual Serotonin (5-HT) Projections to the Nucleus Accumbens Core and Shell: Relation of the 5-HT Transporter to Amphetamine-Induced Neurotoxicity , 2000, The Journal of Neuroscience.

[21]  J. Hollerman,et al.  Reward processing in primate orbitofrontal cortex and basal ganglia. , 2000, Cerebral cortex.

[22]  H. Koppeschaar,et al.  Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress , 2000, Physiology & Behavior.

[23]  K. Lesch,et al.  Reduction in the Density and Expression, But Not G-Protein Coupling, of Serotonin Receptors (5-HT1A) in 5-HT Transporter Knock-Out Mice: Gender and Brain Region Differences , 2000, The Journal of Neuroscience.

[24]  Q. Yan.  Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission , 2000, Brain Research Bulletin.

[25]  Paul J. Harrison,et al.  Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine , 2000, Psychopharmacology.

[26]  C. Benkelfat,et al.  Depressive relapse following acute tryptophan depletion in patients with major depressive disorder , 2000, Journal of psychopharmacology.

[27]  A. Harrison,et al.  Fluoxetine Combined with a Serotonin-1A Receptor Antagonist Reversed Reward Deficits Observed during Nicotine and Amphetamine Withdrawal in Rats , 2001, Neuropsychopharmacology.

[28]  A. Kelley,et al.  Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior , 2001, Neuropsychopharmacology.

[29]  C Reist,et al.  Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. , 2001, American journal of medical genetics.

[30]  Q. Yan,et al.  Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. , 2001, European journal of pharmacology.

[31]  C. Naranjo,et al.  The role of the brain reward system in depression , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  K. Cunningham,et al.  3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. , 2001, The Journal of pharmacology and experimental therapeutics.

[33]  Brian Knutson,et al.  Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens , 2001, The Journal of Neuroscience.

[34]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[35]  Adrian R. Willoughby,et al.  The Medial Frontal Cortex and the Rapid Processing of Monetary Gains and Losses , 2002, Science.

[36]  E. D. de Haan,et al.  Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. , 2002, The American journal of clinical nutrition.

[37]  P. Delgado,et al.  Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion , 2002, Molecular Psychiatry.

[38]  S. Kasper,et al.  Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. , 2002, Archives of general psychiatry.

[39]  Brian Knutson,et al.  A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI , 2003, NeuroImage.

[40]  Trevor W Robbins,et al.  Appetitive Behavior , 2003, Annals of the New York Academy of Sciences.

[41]  V. Arango,et al.  Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice , 2003, Biological Psychiatry.

[42]  R. Elliott,et al.  Differential Response Patterns in the Striatum and Orbitofrontal Cortex to Financial Reward in Humans: A Parametric Functional Magnetic Resonance Imaging Study , 2003, The Journal of Neuroscience.

[43]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[44]  Brian Knutson,et al.  Amygdalar Recruitment during Anticipation of Monetary Rewards , 2003, Annals of the New York Academy of Sciences.

[45]  M. Egan,et al.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Colado,et al.  The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 2003, Pharmacological Reviews.

[47]  C. Carter,et al.  Tryptophan Depletion Alters the Decision-Making of Healthy Volunteers through Altered Processing of Reward Cues , 2003, Neuropsychopharmacology.

[48]  H. Anisman,et al.  Anticipatory Cues Differentially Provoke In Vivo Peptidergic and Monoaminergic Release at the Medial Prefrontal Cortex , 2004, Neuropsychopharmacology.

[49]  K. Hashimoto,et al.  Effect of the acute and chronic administration of the selective 5‐HT6 receptor antagonist SB‐271046 on the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study , 2004, Synapse.

[50]  M. Burmeister,et al.  Meta‐analysis of the association between a serotonin transporter promoter polymorphism (5‐HTTLPR) and anxiety‐related personality traits , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[51]  David Eidelberg,et al.  Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function , 2004, Neuropsychopharmacology.

[52]  C. Cannon,et al.  Is dopamine required for natural reward? , 2004, Physiology & Behavior.

[53]  J. O'Doherty,et al.  Reward representations and reward-related learning in the human brain: insights from neuroimaging , 2004, Current Opinion in Neurobiology.

[54]  R. Pihl,et al.  Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.

[55]  P. Nelemans,et al.  Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review , 2004, Molecular Psychiatry.

[56]  Michael F Egan,et al.  A susceptibility gene for affective disorders and the response of the human amygdala. , 2005, Archives of general psychiatry.

[57]  Sylvia M. L. Cox,et al.  Tryptophan Depletion Disrupts the Motivational Guidance of Goal-Directed Behavior as a Function of Trait Impulsivity , 2005, Neuropsychopharmacology.

[58]  Sean P David,et al.  A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans , 2005, The Journal of Neuroscience.

[59]  Harriet de Wit,et al.  Dopamine Transporter Gene Associated with Diminished Subjective Response to Amphetamine , 2005, Neuropsychopharmacology.

[60]  C. McDougle,et al.  Serotonergic mechanisms of cocaine effects in humans , 1995, Psychopharmacology.

[61]  Christian Büchel,et al.  Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter , 2005, Nature Neuroscience.

[62]  B. Sahakian,et al.  Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users. , 2005, The American journal of psychiatry.